1. Gonadotropin-Releasing Hormone Agonists and the Risks of Type 2 Diabetes and Cardiovascular Disease in Men with Prostate Cancer

   • Philip J. Saylor
   • Nancy L. Keating
   • Matthew R. Smith

   Editorial 18 November 2012 Pages: 255 - 261

   

2. Drugs in Development for Viral Hepatitis

   • Paul J. Pockros

   Editorial 18 November 2012 Pages: 263 - 271

   

3. The Role of Dopamine Agonists in the Treatment of Depression in Patients with Parkinson’s Disease

   • Albert F. G. Leentjens

   Review Article 18 November 2012 Pages: 273 - 286

   

4. Non-Hormonal Treatment Strategies for Vasomotor Symptoms

   • Elise Hall
   • Benicio N. Frey
   • Claudio N. Soares

   Review Article 18 November 2012 Pages: 287 - 304

   

5. Current Options and New Developments in the Treatment of Haemophilia

   • Trisha Wong
   • Michael Recht

   Review Article 18 November 2012 Pages: 305 - 320

   

6. Current and Emerging Pharmacological Treatments for Gastrointestinal Stromal Tumour

   • Kristen N. Ganjoo
   • Shreyaskumar Patel

   Review Article 18 November 2012 Pages: 321 - 330

   

7. Treatment of Viral Conjunctivitis with Antiviral Drugs

   • Chrysanthi L. Skevaki
   • Ioanna E. Galani
   • Athanassios Tsakris

   Review Article 18 November 2012 Pages: 331 - 347

   

8. Sitagliptin/Metformin Fixed-Dose Combination

   • Claudine M. Chwieduk

   Adis Drug Profile 18 November 2012 Pages: 349 - 361

   

9. Fulvestrant

   • Jamie D. Croxtall
   • Kate McKeage

   Adis Drug Evaluation 18 November 2012 Pages: 363 - 380

   

10. Erratum to Intravenous vernakalant: a review of its use in the management of recent-onset atrial fibrillation

    • S. T. Duggan
    • L. J. Scott

    Erratum 18 November 2012 Pages: 381 - 381